about
The association between obesity and back pain in nine countries: a cross-sectional studyVisual impairment and multimorbidity in a representative sample of the Spanish populationBuilt environment and elderly population health: a comprehensive literature review.Impact of multimorbidity on disability and quality of life in the Spanish older populationChronic conditions and sleep problems among adults aged 50 years or over in nine countries: a multi-country study.The burden of disease in Spain: results from the global burden of disease study 2010.Multimorbidity patterns in a national representative sample of the Spanish adult population.The association between obesity and severe disability among adults aged 50 or over in nine high-income, middle-income and low-income countries: a cross-sectional studyRecreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations.Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: a cross-sectional study.Corrigendum: Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendationsGlobal Multimorbidity Patterns: A Cross-Sectional, Population-Based, Multi-Country Study.Diabetes mellitus and its association with central obesity and disability among older adults: a global perspective.Determinants of the components of arterial pressure among older adults--the role of anthropometric and clinical factors: a multi-continent study.Correction: Chronic Conditions and Sleep Problems among Adults Aged 50 years or over in Nine Countries: A Multi-Country Study.Factors associated with active aging in Finland, Poland, and Spain.The Spanish Burden of Disease 2010: Neurological, mental and substance use disorders.Is cognitive impairment associated with suicidality? A population-based study.Physicochemical Stability and Sterility of Standard Parenteral Nutrition Solutions and Simulated Y-Site Admixtures for Neonates.Frailty and health status of older individuals in three European countries: The COURAGE cross-sectional study.Heart failure induced by itraconazole.Role and impact of pharmacists in Spain: a scoping reviewViscosity Differences Between Thickened Beverages Suitable for Elderly Patients with DysphagiaImpact of a pharmaceutical care programme for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: a randomised controlled trial[Viscosity changes in thickened water due to the addition of highly prescribed drugs in geriatrics]
P50
Q28388027-1618DEFA-D2AF-4F7A-B91C-1959BB61B66AQ28392796-0C97E7F6-6F6A-4C99-97C9-CF7E830E4F3FQ34412577-235AB0C5-A13A-4D43-B418-DA7827450F7CQ34465243-79C13CCF-45AA-46F0-B471-FA07386F6E6AQ34640748-FBA0F4D4-6ADA-4674-B607-5F878D8FECEDQ34769417-BD0A1F03-0C01-4B37-8164-94E1554664B4Q35086183-B13EB651-4709-4D20-82E3-CC56B6310566Q35332552-CDCEF7FE-CB1A-48C9-BB5B-17D567D1B633Q35847912-433F2E29-7384-45C3-8634-36B91A4281B1Q37598206-E83E2551-C18A-46C9-AFAD-D862F653169DQ38636837-ADAA700B-D118-451B-9777-668A454A0F6EQ40485360-D5EFC87D-A37C-452E-972E-FB3591B221BAQ41419352-41EED3C0-8408-4A7F-820F-3DCA373AEC19Q41664147-05647758-6CF8-4E62-A2EA-EB56DB15F6C5Q43246652-D5CA37C3-6A56-4FE3-8E8F-B3DC32835355Q44074853-97C0A829-8930-4D3B-A820-1D75770BD4A9Q45711952-A82720F3-7C9C-4F7F-ADB9-F08B32B62BFAQ48219392-0BFFC03B-7DDF-44AC-98E2-925CD9766347Q49719775-796381A7-DC8E-41CF-8AEC-612E32DAD115Q50421139-F3CA37DE-AF85-4AD1-942A-888E8FDA99FFQ50540123-28AB3D4A-1CCD-4582-A13D-FEFECE2D6305Q58114372-CEA8744C-AC97-40B1-9EC7-1963E7A96EADQ60619529-2DD5F3C2-A688-4A4F-A0CF-4BED7A73425FQ60624980-F88EBDED-1B53-43BC-B057-0FA7CE0A5BC5Q85486630-6CA15E47-3B57-45AE-93E5-FA43EEF57390
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Noe Garin
@ast
Noe Garin
@en
Noe Garin
@es
Noe Garin
@nl
Noe Garin
@sl
type
label
Noe Garin
@ast
Noe Garin
@en
Noe Garin
@es
Noe Garin
@nl
Noe Garin
@sl
altLabel
Noe Garin Escriva
@en
prefLabel
Noe Garin
@ast
Noe Garin
@en
Noe Garin
@es
Noe Garin
@nl
Noe Garin
@sl
P106
P21
P31
P496
0000-0002-1559-9453
P569
2000-01-01T00:00:00Z